Microbiological profile of patients with generalized gingivitis undergoing periodontal therapy and administration of Bifidobacterium animalis subsp. lactis HN019: A randomized clinical trial.
- 2024-11-11
- RCT · n = 30
- PloS one 19(11)
- Flavia Furlaneto
- Yara Loyanne de Almeida Silva Levi
- Débora de Souza Ferreira Sávio
- Izadora Cianfa Firmino da Silveira
- Adriana Miranda de Oliveira
- Talita Gomes Baêta Lourenço
- Marcella Costa Ribeiro
- Pedro Henrique Felix Silva
- Sergio Luiz de Souza Salvador
- Ana Paula Vieira Colombo
- Michel Reis Messora
- PubMed: 39527605
- DOI: 10.1371/journal.pone.0310529
- High evidence
The Probiotic group had a lower percentage of BOMP when compared with the Placebo group at 8 weeks (p<0.0001). The adjuvant use of B. lactis HN019 alongside conventional therapy enhanced the reduction in BOMP
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes